Wells Fargo Board of Directors Announces Intention to Name CEO, Charlie Scharf, Chairman
In addition, the Board awarded Mr. Scharf a one-time special equity grant consisting of $30 million in Restricted Share Rights and 1,046,000 Stock Options.
These actions reflect the Board's desire to retain Mr. Scharf as the CEO of the Company and to recognize his leadership in transforming Wells Fargo, including creating significant shareholder value and positioning the company for future success. Under his leadership, he has built an outstanding management team, significantly strengthened the company's risk and control infrastructure, improved its reputation, achieved critical regulatory milestones, and delivered a strong financial performance, while making strategic investments in driving growth of our core businesses.
The award will vest (and become exercisable for stock options) on a pro rata basis following the fourth, fifth and sixth anniversaries of the grant date. The Board believes the award design, coupled with our stock ownership policy, promotes further alignment of Mr. Scharf's compensation with long-term shareholder value creation.
Steven Black, current Chairman of the Board, Wells Fargo, said: 'We are thrilled to recognize Charlie's significant contributions to Wells Fargo and are planning to appoint him as Chairman of the Board. We also plan to appoint a Lead Independent Director to maintain independent Board leadership. The special equity award is designed to acknowledge Charlie's role in leading Wells Fargo through an unprecedented transformation, creating shareholder value and positioning the Company for the future. We look forward to Charlie's continued guidance and strategic direction as we navigate the future."
Mr. Scharf stated: 'Over the last several years, our Operating Committee and our 213,000 employees have executed a multi-faceted transformation under extremely difficult circumstances. It is a privilege to lead Wells Fargo and our talented and dedicated team, and I look forward to building on our significant momentum to continue improving our performance and market position in everything we do.'
More information about the Board's leadership and the equity award is available in the Company's Form 8-K filed with the Securities and Exchange Commission today.
About Wells Fargo
Wells Fargo & Company (NYSE: WFC) is a leading financial services company that has approximately $2.0 trillion in assets. We provide a diversified set of banking, investment and mortgage products and services, as well as consumer and commercial finance, through our four reportable operating segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth & Investment Management. Wells Fargo ranked No. 33 on Fortune's 2025 rankings of America's largest corporations.
Cautionary Statement About Forward-Looking Statements
This news release contains forward-looking statements about our future financial performance and business. Because forward-looking statements are based on our current expectations and assumptions regarding the future, they are subject to inherent risks and uncertainties. Do not unduly rely on forward-looking statements as actual results could differ materially from expectations. Forward-looking statements speak only as of the date made, and we do not undertake to update them to reflect changes or events that occur after that date. For information about factors that could cause actual results to differ materially from our expectations, refer to our reports filed with the Securities and Exchange Commission, including the discussion under 'Risk Factors' in our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission and available on its website at www.sec.gov.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Bitcoin Asset Manager Parataxis to Go Public in $400M SPAC Deal Backed by SilverBox
Digital asset manager Parataxis Holdings is officially going public through a SPAC deal with SilverBox Corp IV, confirming earlier plans to list, it announced in a press release on Wednesday. The new entity will be called Parataxis Holdings Inc. and aims to trade under the ticker 'PRTX' on the New York Stock Exchange (NYSE). At a $10 share price, the deal values the combined company at $400 million, with the potential to double that figure if Parataxis exercises the right to raise an additional $400 million through a share purchase agreement. About $31 million has already been raised and earmarked for purchasing bitcoin (BTC), giving future shareholders immediate exposure to the asset. Parataxis manages bitcoin in an active strategy that blends market exposure with yield-generating techniques. Unlike firms that simply hold BTC, Parataxis seeks to generate income through low-volatility trading and treasury-style operations. The platform is run by veterans from Parataxis Capital Management and serves institutional client, including pension firms and family offices. In June, Parataxis made its first international move by acquiring a controlling stake in Bridge Biotherapeutics, a healthcare firm listed on South Korea's KOSDAQ. That firm will be renamed Parataxis Korea and serve as a regional base for its bitcoin treasury strategy. Since the announcement, Bridge shares have jumped 350%, showing strong investor demand for the bitcoin-proxy play. South Korea offers a large user base, political support for digital assets, and notably, no spot Bitcoin ETF — making the market fertile ground for BTC-focused public firms, the company said. Similar strategies have gained traction in Japan, where companies like Metaplanet have seen share prices surge after pivoting to bitcoin. The Parataxis-SPAC deal will also allow the firm to expand its U.S. treasury operations and explore other 'special situations' investments. If successful, Parataxis could become one of the few publicly listed companies offering direct and active exposure to bitcoin outside of an ETF structure. The transaction is expected to close pending shareholder approval and a review from the Securities and Exchange Commission. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon. AT&T to pay $177 million in data breach settlement. Here's how to claim up to $5,000 Wells Fargo is rolling out company wide AI. It says everyone from branch tellers to investment bankers will benefit Want to get smarter? Neuroscience says 5 simple steps significantly boost memory, learning, and cognition Heartflow, a California-based medtech company that utilizes AI with imaging and diagnostics software to help evaluate cardiac and coronary diseases, is looking to list shares on the Nasdaq. In paperwork filed on Friday with the Securities and Exchange Commission (SEC), Heartflow said it plans to offer 12.5 million shares, priced between $15 and $17. That could potentially raise more than $208 million. According to Reuters, Heartflow's target valuation could be as high as $1.3 billion. The company plans to trade under the ticker 'HTFL.' Personalized 3D-models of people's hearts Heartflow uses AI and other technology to scan patients for coronary and cardiac problems, creating three-dimensional models of patients' hearts. The Food and Drug Administration (FDA) gave the software the green light in 2022, and it's now being used in some markets to diagnose patients. Additionally, the company got a leg up last year when the U.S. Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage to include platforms that use imaging results to look for signs of coronary disease, and the American Medical Association (AMA) issued a new Category I CPT code for those platforms. That gives doctors and clinics the go-ahead to start using the technology on a broader scale starting next year. According to the company's SEC filing, Heartflow says that as of the end of March 2025, it's been used to assess more than 400,000 patients. Revenues are growing but profits are elusive Heartflow generated $125.8 million in 2024, a 44% increase over the $87.2 million it made the year before, the company says. Revenue likewise grew 39% for the first quarter of 2025 to $37.2 million. However, the company saw a net loss of $96.4 million in 2024, wider than its net loss of $95.7 million in 2023. It warns in the filing that it expects to incur 'substantial losses in the foreseeable future [and] may not be able to achieve or sustain profitability.' Bain Capital, Panorama Point Partners, and Capricorn Investment Group are among Heartflow's backers, according to Crunchbase. Bain led its most recent fundraising round, a Series F round in 2023, which raised $215 million. This is not the first time that Heartflow has attempted to go public. The company had planned to merge with a special purpose acquisition company during the SPAC frenzy of the early pandemic years, but it halted the plan in 2022, citing 'unfavorable market conditions,' as Fierce Biotech reported. Heartflow's IPO comes on the heels of another growing medtech company's public debut. Carlsmed, which specializes in AI-driven spine surgery technology, recently went public as well, with shares trading on July 23. Since then, the stock is down around 4.5%. Heartflow has not said when it plans to list its stock, although IPO calendar websites say the listing is expected this week. The company declined to comment on the timeline when reached by Fast Company. This post originally appeared at to get the Fast Company newsletter: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Essent Group (ESNT) Reports Earnings Tomorrow: What To Expect
Mortgage insurance provider Essent Group (NYSE:ESNT) will be announcing earnings results this Friday before market hours. Here's what you need to know. Essent Group beat analysts' revenue expectations by 2.1% last quarter, reporting revenues of $317.6 million, up 6.4% year on year. It was a mixed quarter for the company, with net premiums earned in line with analysts' estimates but EPS in line with analysts' estimates. Is Essent Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Essent Group's revenue to grow 1.2% year on year to $316.8 million, slowing from the 20.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.71 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Essent Group has missed Wall Street's revenue estimates three times over the last two years. Looking at Essent Group's peers in the property & casualty insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Root delivered year-on-year revenue growth of 32.4%, beating analysts' expectations by 7.5%, and Mercury General reported revenues up 13.2%, topping estimates by 2%. Mercury General's stock price was unchanged following the results. Read our full analysis of Root's results here and Mercury General's results here. Investors in the property & casualty insurance segment have had fairly steady hands going into earnings, with share prices down 1% on average over the last month. Essent Group is down 2.9% during the same time and is heading into earnings with an average analyst price target of $65 (compared to the current share price of $57.85). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
